This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Davidson NE , Morrow M , Kopans DB , Koerner FC
Case 35-2005: A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node
New England Journal of Medicine. 2005 ;353(20) :2177-2185
Notes00284793 (ISSN) Cited By: 0; Export Date: 25 May 2006; Source: Scopus CODEN: NEJMA Language of Original Document: English Correspondence Address: Davidson, N.E.; Johns Hopkins University; School of Medicine Baltimore, MD, United States Chemicals/CAS: tamoxifen, 10540-29-1, Antineoplastic Agents; Aromatase Inhibitors; Tamoxifen, 10540-29-1 References: Greene, F.L., Page, D.L., Fleming, I.D., (2002) AJCC Cancer Staging Manual. 6th Ed., New York: Springer-Verlag; Sobin, L.H., Wittekind, C., (2002) TNM: Classification of Malignant Tumours. 6th Ed., New York: Wiley-Liss; Singletary, S.E., Greene, F.L., Sobin, L.H., Classification of isolated tumor cells: Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual (2003) Cancer, 98, pp. 2740-2741; Carter, B.A., Jensen, R.A., Simpson, J.F., Page, D.L., Benign transport of breast epithelium into axillary lymph nodes after biopsy (2000) Am J Clin Pathol, 113, pp. 259-265; Wong, S.L., Edwards, M.J., Chao, C., Predicting the status of the nonsentinel axillary nodes: A multicenter study (2001) Arch Surg, 136, pp. 563-568; Chu, K.U., Turner, R.R., Hansen, N.M., Brennan, M.B., Giuliano, A.E., Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis (1999) Ann Surg Oncol, 6, pp. 756-761; Nos, C., Harding-MacKean, C., Freneaux, P., Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases (2003) Br J Surg, 90, pp. 1354-1360; Viale, G., Maiorano, E., Pruneri, G., Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy (2005) Ann Surg, 241, pp. 319-325; Van Zee, K.J., Manasseh, D.M., Bevilacqua, J.L., A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy (2003) Ann Surg Oncol, 10, pp. 1140-1151; Leidenius, M.H., Vironen, J.H., Riihela, M.S., The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases (2005) Eur J Surg Oncol, 31, pp. 13-18; Mignotte, H., Treilleux, I., Faure, C., Nessah, K., Bremond, A., Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients (2002) Eur J Surg Oncol, 28, pp. 623-626; Kamath, V.J., Giuliano, R., Dauway, E.L., Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: A study to evaluate the need for complete axillary lymph node dissection (2001) Arch Surg, 136, pp. 688-692; Hwang, R.F., Krishnamurthy, S., Hunt, K.K., Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer (2003) Ann Surg Oncol, 10, pp. 248-254; Menes, T.S., Tartter, P.I., Mizrachi, H., Constantino, J., Estabrook, A., Smith, S.R., Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases (2005) J Am Coll Surg, 200, pp. 323-327; Goyal, A., Douglas-Jones, A., Newcombe, R.G., Mansel, R.E., Predictors of non-sentinel lymph node metastasis in breast cancer patients (2004) Eur J Cancer, 40, pp. 1731-1737; Travagli, J.P., Atallah, D., Mathieu, M.C., Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: Predictors of non-sentinel lymph node metastasis (2003) Eur J Surg Oncol, 29, pp. 403-406; Fournier, K., Schiller, A., Perry, R.R., Laronga, C., Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection (2004) Ann Surg, 239, pp. 859-863; Sachdev, U., Murphy, K., Derzie, A., Jaffer, S., Bleiweiss, I.J., Brower, S., Predictors of nonsentinel lymph node metastasis in breast cancer patients (2002) Am J Surg, 183, pp. 213-217; Lambert, L., Hunt, K.K., Hwang, R.F., Validation of a breast cancer nomogram for predicting additional nodal metastases after positive sentinel node biopsy (2005) Ann Surg Oncol, 12 (1 SUPPL.), pp. S17, abstract; Langer, I., Marti, W.R., Guller, U., Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: Prospective analysis of 150 patients after SLN biopsy (2005) Ann Surg, 241, pp. 152-158; Fant, J.S., Grant, M.D., Knox, S.M., Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection (2003) Ann Surg Oncol, 10, pp. 126-130; Guenther, J.M., Hansen, N.M., DiFronzo, L.A., Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes (2003) Arch Surg, 138, pp. 52-56; Greco, M., Agresti, R., Cascinelli, N., Breast cancer patients treated without axillary surgery: Clinical implications and biologic analysis (2000) Ann Surg, 232, pp. 1-7; Holmberg, S.B., Crivellari, D., Zahrieh, J., A randomized trial comparing axillary clearance versus no axillary clearance in patients older than 60 years with breast cancer: First results of International Breast Cancer Study Group Trial 10-93 (2004) J Clin Oncol, 22 (SUPPL.), pp. 4S, abstract; Fisher, B., Anderson, S., Bryant, J., Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer (2002) N Engl J Med, 347, pp. 1233-1241; Overgaard, M., Hansen, P.S., Overgaard, J., Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial (1997) N Engl J Med, 337, pp. 949-955; Overgaard, M., Jensen, M.B., Overgaard, J., Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial (1999) Lancet, 353, pp. 1641-1648; Louis-Sylvestre, C., Clough, K., Asselain, B., Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up (2004) J Clin Oncol, 22, pp. 97-101; Kaae, S., Johansen, H., Does simple mastectomy followed by irradiation offer survival comparable to radical procedures? (1977) Int J Radiat Oncol Biol Phys, 2, pp. 1163-1166; Langlands, A.O., Prescott, R.J., Hamilton, T., A clinical trial in the management of operable cancer of the breast (1980) Br J Surg, 67, pp. 170-174; Atkins, H., Hayward, J.L., Klugman, D.J., Wayte, A.B., Treatment of early breast cancer: A report after ten years of a clinical trial (1972) BMJ, 2, pp. 423-429; Hayward, J.L., The Guy's trial of treatments of "early" breast cancer (1977) World J Surg, 1, pp. 314-316; Orr, R.K., The impact of prophylactic axillary node dissection on breast cancer survival - A Bayesian meta-analysis (1999) Ann Surg Oncol, 6, pp. 109-116; Veronesi, U., Paganelli, G., Viale, G., A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer (2003) N Engl J Med, 349, pp. 546-553; Mansel, R.E., Goyal, A., Newcombe, R.G., Objective assessment of lymphedema, shoulder function and sensory deficit after sentinel node biopsy for invasive cancer: ALMANAC trial (2004) Breast Cancer Res Treat, 88 (1 SUPPL.), pp. S12, abstract; Galper, S., Recht, A., Silver, B., Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone (1999) Int J Radiat Oncol Biol Phys, 45, pp. 1157-1166; Hayes, D.F., Markers of increased risk for failure of adjuvant therapies (2003) Breast, 12, pp. 543-549; Quiet, C.A., Ferguson, D.J., Weichselbaum, R.R., Hellman, S., Natural history of node-negative breast cancer: A study of 826 patients with long-term follow-up (1995) J Clin Oncol, 13, pp. 1144-1151; Quiet, C.A., Ferguson, D.J., Weichselbaum, R.R., Hellman, S., Natural history of node-positive breast cancer: The curability of small cancers with a limited number of positive nodes (1996) J Clin Oncol, 14, pp. 3105-3111; Fisher, B., Bryant, J., Dignam, J., Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less (2002) J Clin Oncol, 20, pp. 4141-4149; Hansen, N.M., Grube, B.J., Te, W., Brennan, M.L., Turner, R., Guiliano, A.E., Clinical significance of axillary micrometastases in breast cancer: How small is too small? (2001) Proc Am Soc Clin Oncol, 20, pp. 24a, abstract; Kattan, M.W., Giri, D., Panageas, K.S., A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy (2004) Cancer, 101, pp. 2509-2515; Paik, S., Shak, S., Tang, G., A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer (2004) N Engl J Med, 351, pp. 2817-2826; Paik, S., Shak, S., Tang, G., Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefit from tamoxifen in NSABP study B-14 and chemotherapy in NSABP study B-20 (2004) Proceedings of the 27th Annual San Antonio Breast Cancer Symposium, San Antonio, Tex., December 8-11, abstract; Goldhirsch, A., Glick, J.H., Gelber, R.D., Coates, A.S., Thurlimann, B., Senn, H.-J., Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 (2005) Ann Oncol, 16, pp. 1569-1583; Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials (2005) Lancet, 365, pp. 1687-1717; Howell, A., Cuzick, J., Baum, M., Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer (2005) Lancet, 365, pp. 60-62; Thurlimann, B.J., Keshaviah, A., Mouridsen, J., BIG 1-98: Randomized double phase III study to evaluate letrozole (L) vs tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptorpositive breast cancer (2005) J Clin Oncol, 23, p. 65, abstract; Winer, E.P., Hudis, C., Burstein, H.J., American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004 (2005) J Clin Oncol, 23, pp. 619-629; Colleoni, M., Rotmensz, G., Peruzzotti, G., Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement (2005) J Clin Oncol, 23, pp. 1379-1389; Ravdin, P.M., Siminoff, L.A., Davis, G.J., Computer program to assist in making decision about adjuvant therapy for women with early breast cancer (2001) J Clin Oncol, 19, pp. 980-991; Olivotto, I.A., Bajdik, C.D., Ravdin, P.M., Population-based validation of the prognostic model ADJUVANT! For early breast cancer (2005) J Clin Oncol, 23, pp. 2716-2725; Shapiro, C.L., Recht, A., Side effects of adjuvant treatment of breast cancer (2001) N Engl J Med, 344, pp. 1997-2008.